Q1 2025 Cumberland Pharmaceuticals Inc Earnings Call Transcript

May 6, 2025 / 08:30 PM GMT

Release Date Price: $4.41 (-1.34%)

Transcript 10-Q8-K

Key Points

Positve

Cumberland Pharmaceuticals Inc (CPIX) reported a 38% increase in revenue for the first quarter of 2025, reaching $11.7 million.
The company achieved a net profit of $1.26 million for the quarter, with adjusted earnings of $2.4 million.
CPIX's balance sheet improved significantly, with $70 million in total assets and a substantial decrease in debt.
The approval of Vibative in China provides access to the world's second-largest pharmaceutical market.
Positive top-line results from the phase 2 study of ifitraban in Duchenne muscular dystrophy patients mark a breakthrough in addressing cardiac complications.

Negative

The company faces risks and uncertainties, including natural disasters, economic downturns, and public health epidemics, which could affect future results.
CPIX's total liabilities stand at $42 million, indicating a need for continued financial management.
The company is still addressing FDA issues at the new manufacturing site for Vaprosal, which could delay product approval.
Despite positive developments, actual results may differ materially from expectations due to various risk factors.
CPIX's financial performance is heavily reliant on the success of its marketed brands and clinical pipeline, which may face challenges.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CPIX.OQ - Cumberland Pharmaceuticals Inc
Q1 2025 Cumberland Pharmaceuticals Inc Earnings Call
May 06, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Reported at the company's request and will be archived on its website for one year from today's date. I would now like to turn the call over to Molly Agus, account supervisor at the Dalton Agency who handles Cumberland's communications. Molly, please proceed.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Hello, everyone, and thank you for joining us today. This afternoon, Cumberland issued a press release announcing its first quarter financial results. The release also provided an operational update, including key developments during the quarter.

The

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.